• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
PublishGo to AppAI Superconnector
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEW
    Legal
    Terms of usePrivacy policyCookie policy

    CorVel Announces Revenues and Earnings

    8/5/25 6:15:00 AM ET
    $CRVL
    Specialty Insurers
    Finance
    Get the next $CRVL alert in real time by email

    FORT WORTH, Texas, Aug. 05, 2025 (GLOBE NEWSWIRE) -- CorVel Corporation (NASDAQ:CRVL) announced the results for the quarter ended June 30, 2025. Revenues for the quarter were $235 million, an increase from $212 million in the June quarter of 2024. Earnings per share for the quarter were $0.52, compared to $0.42 in the same quarter of the prior year.  The earnings per share numbers for the current and prior year have been adjusted to reflect the three-for-one stock split of its common stock which was paid on December 24, 2024.

    First Quarter Fiscal Year 2026 Highlights 

    • Revenue increased 11% to $235 million, compared to first quarter of fiscal year 2025.
    • Gross profit increased 18% to $56.8 million, at 24% gross margin, compared to first quarter of fiscal year 2025 gross profit of $48.2 million.
    • Diluted earnings per share increased 24% to $0.52, compared to first quarter of fiscal year 2025 diluted earnings per share of $0.42.
    • Exited the quarter with $202 million of cash, cash equivalents, and no borrowings.
    • The Company repurchased $9.6 million of common stock during the quarter.

    The results achieved in the quarter were driven by disciplined execution and a clear focus on long-term strategy. CorVel's teams continue to advance innovation initiatives, including targeted R&D in agentic AI, strengthen operational capabilities, enhance customer outcomes, and deliver sustainable value for shareholders.

    As part of CorVel's ongoing commitment to innovation and long-term growth, the Company has completed the acquisition of assets and key talent from a privately held technology firm. The acquired assets include proprietary tools and intellectual property that are expected to enhance the capabilities of the CERIS group health division. This acquisition provides additional strength to foundational technologies and aligns with the strategic vision of delivering advanced, scalable solutions to CERIS partners. The integration of these assets will enhance innovation, reduce time-to-market, and increase the value provided in many areas. The transaction was completed in July and the Company expects the transaction to be accretive to growth over the medium term.

    Safe Harbor Statement under the Private Securities Litigation Reform Act of 1995

    All statements included in this press release, other than statements or characterizations of historical fact, are forward-looking statements. These forward-looking statements are based on the Company's current expectations, estimates and projections about the Company, management's beliefs, and certain assumptions made by the Company, and events beyond the Company's control, all of which are subject to change. Such forward-looking statements include, but are not limited to, improved productivity resulting from automation and augmentation across enterprise business systems.  These forward-looking statements are not guarantees of future results and are subject to risks, uncertainties and assumptions that could cause the Company's actual results to differ materially and adversely from those expressed in any forward-looking statement results of operations and financial condition is greater than our initial assessment.  The risks and uncertainties referred to above include but are not limited to factors described in this press release and the Company's filings with the Securities and Exchange Commission, including but not limited to "Risk Factors" in the Company's Annual Report on Form 10-K for the year ended March 31, 2025, and the Company's Quarterly Report on Form 10-Q for the quarters ended June 30, 2024, September 30, 2024, and December 31, 2024. The forward-looking statements in this press release speak only as of the date they are made. The Company undertakes no obligation to revise or update publicly any forward-looking statement for any reason.



    CorVel Corporation

    Quarterly Results – Income Statement

    Quarters Ended June 30, 2025 (unaudited) and June 30, 2024 (unaudited)
     
    Quarter Ended June 30, 2025  June 30, 2024 
    Revenues $234,711,000  $211,722,000 
    Cost of revenues  177,950,000   163,567,000 
    Gross profit  56,761,000   48,155,000 
    General and administrative  21,478,000   20,120,000 
    Income from operations  35,283,000   28,035,000 
    Income tax provision  8,048,000   6,458,000 
    Net income $27,235,000  $21,577,000 
    Earnings Per Share:      
    Basic $0.53  $0.42 
    Diluted $0.52  $0.42 
    Weighted Shares      
    Basic  51,352,000   51,366,000 
    Diluted  51,912,000   51,939,000 



    CorVel Corporation

    Quarterly Results – Condensed Balance Sheet

    June 30, 2025 (unaudited) and March 31, 2025 
     
      June 30, 2025  March 31, 2025 
    Cash $202,025,000  $170,584,000 
    Customer deposits  108,138,000   101,472,000 
    Accounts receivable, net  101,975,000   104,126,000 
    Prepaid taxes and expenses  9,486,000   10,507,000 
    Property, net  108,440,000   92,052,000 
    Goodwill and other assets  46,779,000   46,410,000 
    Right-of-use asset, net  20,605,000   20,825,000 
    Total $597,448,000  $545,976,000 
    Accounts and taxes payable $30,689,000  $16,792,000 
    Accrued liabilities  204,532,000   187,244,000 
    Long-term lease liabilities  19,695,000   19,953,000 
    Paid-in capital  253,339,000   250,412,000 
    Treasury stock  (841,127,000)  (831,510,000)
    Retained earnings  930,320,000   903,085,000 
    Total $597,448,000  $545,976,000 



    Contact: Melissa Storan

    Phone: 949-851-1473

    www.corvel.com



    Primary Logo

    Get the next $CRVL alert in real time by email

    Crush Q3 2025 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $CRVL

    DatePrice TargetRatingAnalyst
    More analyst ratings

    $CRVL
    SEC Filings

    View All

    SEC Form 8-K filed by CorVel Corp.

    8-K - CORVEL CORP (0000874866) (Filer)

    8/12/25 6:48:26 PM ET
    $CRVL
    Specialty Insurers
    Finance

    SEC Form 10-Q filed by CorVel Corp.

    10-Q - CORVEL CORP (0000874866) (Filer)

    8/7/25 4:30:49 PM ET
    $CRVL
    Specialty Insurers
    Finance

    CorVel Corp. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits

    8-K - CORVEL CORP (0000874866) (Filer)

    8/4/25 7:30:29 PM ET
    $CRVL
    Specialty Insurers
    Finance

    $CRVL
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    SEC Form 4 filed by Director Michael Jeffrey J

    4 - CORVEL CORP (0000874866) (Issuer)

    8/11/25 7:54:19 PM ET
    $CRVL
    Specialty Insurers
    Finance

    SEC Form 4 filed by Director Jessup R Judd

    4 - CORVEL CORP (0000874866) (Issuer)

    8/11/25 7:07:02 PM ET
    $CRVL
    Specialty Insurers
    Finance

    SEC Form 4 filed by Director Hamerslag Steven J

    4 - CORVEL CORP (0000874866) (Issuer)

    8/11/25 6:43:23 PM ET
    $CRVL
    Specialty Insurers
    Finance

    $CRVL
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    CorVel Announces Revenues and Earnings

    FORT WORTH, Texas, Aug. 05, 2025 (GLOBE NEWSWIRE) -- CorVel Corporation (NASDAQ:CRVL) announced the results for the quarter ended June 30, 2025. Revenues for the quarter were $235 million, an increase from $212 million in the June quarter of 2024. Earnings per share for the quarter were $0.52, compared to $0.42 in the same quarter of the prior year.  The earnings per share numbers for the current and prior year have been adjusted to reflect the three-for-one stock split of its common stock which was paid on December 24, 2024. First Quarter Fiscal Year 2026 Highlights  Revenue increased 11% to $235 million, compared to first quarter of fiscal year 2025.Gross profit increased 18% to $5

    8/5/25 6:15:00 AM ET
    $CRVL
    Specialty Insurers
    Finance

    CorVel Announces Revenues and Earnings

    FORT WORTH, Texas, May 22, 2025 (GLOBE NEWSWIRE) -- CorVel Corporation (NASDAQ:CRVL) announced the results for the quarter and fiscal year ended March 31, 2025. Revenues for the quarter were $232 million, an increase from $207 million in the March quarter of 2024. Earnings per share for the quarter were $0.51, compared to $0.37 in the same quarter of the prior year.  Revenues for the fiscal year ended March 31, 2025 were $896 million, an increase from $795 million during the fiscal year ended March 31, 2024. Earnings per share for the fiscal year ended March 31, 2025 were $1.83, compared to $1.47 during the fiscal year ended March 31, 2024. The earnings per share numbers for the current an

    5/22/25 6:15:00 AM ET
    $CRVL
    Specialty Insurers
    Finance

    STAAR Surgical Announces Changes to Board of Directors

    STAAR Surgical Company (NASDAQ:STAA), the global leader in phakic IOLs with the EVO family of Implantable Collamer® Lenses (EVO ICL™) for vision correction, today announced changes to its Board of Directors. The Company announced that the Board appointed Louis E. Silverman, who served on the Company's Board from 2014-2022, as a director, effective April 24, 2025. The Company also announced that Aimee S. Weisner, who has served as a director since 2022, has chosen not to stand for re-election to the Board when her term expires at the Company's 2025 annual meeting of shareholders in June. In addition, the Company announced that Wei Jiang, who has served as a director since 2024, has agreed to

    4/24/25 5:00:00 PM ET
    $AZN
    $CRVL
    $LLY
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Specialty Insurers
    Finance

    $CRVL
    Leadership Updates

    Live Leadership Updates

    View All

    CorVel Corporation Appoints Sarah Scott as Executive Vice President of Product

    FORT WORTH, Texas, Feb. 13, 2025 (GLOBE NEWSWIRE) -- CorVel Corporation (NASDQ: CRVL), a national provider of risk management solutions, today announced the promotion of Sarah Scott to Executive Vice President of Product. In her expanded role, Sarah will be responsible for defining and driving the overall product vision and strategy, from ideation to launch and ongoing optimization. Sarah's leadership will ensure the company continues to deliver innovative solutions that create value and meet the evolving needs of its partners. Throughout her 25 years with CorVel, Sarah has been instrumental in the company's success. In her previous role as Vice President of Network Solutions, Sarah playe

    2/13/25 7:25:00 AM ET
    $CRVL
    Specialty Insurers
    Finance

    CorVel Announces Retirement of V. Gordon Clemons

    FORT WORTH, Texas, Nov. 29, 2024 (GLOBE NEWSWIRE) -- CorVel Corporation (NASDAQ:CRVL) announces V. Gordon Clemons is electing to retire as a member of the Company's Board of Directors (the "Board") and as Chairman of the Board, effective November 26, 2024, after 37 years of service. Clemons founded CorVel Corporation in 1988 and has served as Chairman of the Board since the Company went public in 1991. Effective upon Clemons' retirement, Michael G. Combs, the Company's President and Chief Executive Officer, was appointed as the new Chairman of the Board. Clemons has been an advisor to Combs since 2017, and he will continue to be available to Combs as an outside consultant. "Building CorVe

    11/29/24 1:30:00 PM ET
    $CRVL
    Specialty Insurers
    Finance

    CorVel Appoints Jeff Gurtcheff Vice President of Enterprise Comp

    FORT WORTH, Texas , Feb. 02, 2022 (GLOBE NEWSWIRE) -- CorVel, a national provider of risk management solutions, has named Jeff Gurtcheff as Vice President of Enterprise Comp. With more than 30 years of experience, Gurtcheff brings a deep understanding of the industry with strategic leadership and management expertise. As Vice President of Enterprise Comp, Gurtcheff will refine product vision and strategy related to corporate goals and manage resources responsible for regulatory compliance, claims handling, quality, and standards and procedures. His position will also support product line profit growth by developing improved processes, risk management practices, and analytical reporting.

    2/2/22 7:08:00 AM ET
    $CRVL
    Specialty Insurers
    Finance

    $CRVL
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13G/A filed by CorVel Corp. (Amendment)

    SC 13G/A - CORVEL CORP (0000874866) (Subject)

    2/14/24 6:45:55 PM ET
    $CRVL
    Specialty Insurers
    Finance

    SEC Form SC 13G/A filed by CorVel Corp. (Amendment)

    SC 13G/A - CORVEL CORP (0000874866) (Subject)

    2/13/24 5:02:29 PM ET
    $CRVL
    Specialty Insurers
    Finance

    SEC Form SC 13G/A filed by CorVel Corp. (Amendment)

    SC 13G/A - CORVEL CORP (0000874866) (Subject)

    2/13/24 4:05:36 PM ET
    $CRVL
    Specialty Insurers
    Finance

    $CRVL
    Financials

    Live finance-specific insights

    View All

    CorVel Announces Revenues and Earnings

    FORT WORTH, Texas, Aug. 05, 2025 (GLOBE NEWSWIRE) -- CorVel Corporation (NASDAQ:CRVL) announced the results for the quarter ended June 30, 2025. Revenues for the quarter were $235 million, an increase from $212 million in the June quarter of 2024. Earnings per share for the quarter were $0.52, compared to $0.42 in the same quarter of the prior year.  The earnings per share numbers for the current and prior year have been adjusted to reflect the three-for-one stock split of its common stock which was paid on December 24, 2024. First Quarter Fiscal Year 2026 Highlights  Revenue increased 11% to $235 million, compared to first quarter of fiscal year 2025.Gross profit increased 18% to $5

    8/5/25 6:15:00 AM ET
    $CRVL
    Specialty Insurers
    Finance

    STAAR Surgical Announces Changes to Board of Directors

    STAAR Surgical Company (NASDAQ:STAA), the global leader in phakic IOLs with the EVO family of Implantable Collamer® Lenses (EVO ICL™) for vision correction, today announced changes to its Board of Directors. The Company announced that the Board appointed Louis E. Silverman, who served on the Company's Board from 2014-2022, as a director, effective April 24, 2025. The Company also announced that Aimee S. Weisner, who has served as a director since 2022, has chosen not to stand for re-election to the Board when her term expires at the Company's 2025 annual meeting of shareholders in June. In addition, the Company announced that Wei Jiang, who has served as a director since 2024, has agreed to

    4/24/25 5:00:00 PM ET
    $AZN
    $CRVL
    $LLY
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Specialty Insurers
    Finance